Sakkinen et al.
Sakkinen et al. (1) derived multiple factors of insulin resistance syndrome through factor analysis of 21 metabolic and hemostatic variables. They used orthogonal transformation (varimax rotation in SAS computer software) to rotate the factors in order to achieve clearer interpretability. Thus, the derived factors including body mass, insulin/ glucose, lipids, blood pressure, and so on are "uncorrelated." While their approach is statistically sound, the logic is not consistent with the theory of insulin resistance syndrome, which postulates a common underlying biologic process for the close interrelation among obesity, hyperinsulinemia, glucose intolerance, dyslipidemia, and other metabolic disorders (2) . There are substantial data that these components are all intercorrelated, both statistically and biologically. Thus, the "uncorrelated" factors identified from this study and several previous analyses may merely reflect a statistical artifact rather than a biologic reality.
To test the clustering of the components as well as a unified mechanism that underlies various metabolic abnormalities, an alternative rotation method, an oblique rotation (promax rotation in SAS computer software), can be used to produce correlated factors (3). Then second-order factor(s) can be derived by factor analyzing the correlation matrix of the common factors obtained from the first step. This can also be achieved by confirmatory factor analysis (4), which is a theory-testing method as opposed to a datadriven method like explanatory factor analysis. This modelfitting procedure allows one to test the ability of the hypothesized factor structure to account for the observed covariance by examining the overall fit of the model. The analyses can be carried out using SAS PROC CALIS (5) or specialized computer programs, such as LISREL 8 (6) . In addition, the confirmatory factor analysis procedure allows for a test of the equality of factor structure between different groups (e.g., male and female) by comparing the model fit of competing models with and without certain constraints on factor loadings (6). 
TWO AUTHORS REPLY
We thank Dr. Hu for his letter (1) regarding our recently published article on the clustering of metabolic and hemostatic risk markers in the insulin resistance syndrome (2), and we agree that the methods we and some others (3-6) have used were essentially exploratory and not confirmatory. Hu maintains that our use of orthogonal transformation in the factor analyses contradicts the current theory of interrelation among the several facets attributed to the insulin resistance syndrome. As was indicated in our article (2), however, four of the 21 measured risk variables (fasting insulin, triglycerides, factor IXc, and fibrin fragment Ddimer) each clustered with two of the seven factors we identified, suggesting points of pathophysiologic commonality among the statistically uncorrelated factors. As Meigs noted in his commentary, "[t]he pattern of overlap provides insight into the underlying structure of the syndrome" (7, p. 908). For example, the overlapping of fibrin fragment D-dimer on both the procoagulation and inflammation factors suggests a nexus between inflammation and thrombin activity.
Our goal in using explanatory factor analysis was to further elucidate relations among putative hemostatic and metabolic components of the insulin resistance syndrome. We did not engage in statistical hypothesis testing of the sort proposed by Hu in his discussion of confirmatory factor analysis (1); rather, we sought to guide subsequent investigations by attempting to discern risk marker relations that can be obscured by the many intercorrelations among the markers. Fundamentally, we believe that the current, limited understanding of the pathophysiology of the insulin resistance syndrome warrants further exploration of this type. 
RE: "RACIAL DIFFERENCES IN REPORTED LYME DISEASE INCIDENCE"
We would like to congratulate Fix et al. (1) on a clear study about the reported incidence of Lyme disease. The study was well carried out, especially the section on surveillance procedure. It shows that there is a decrease in the discrepancy of reported incidence between Whites and African Americans when looking at a focus of endemicity. However, there is still a significant difference in the reported incidence of Lyme disease among Whites and African Americans in Maryland's focus of endemicity, the Upper Eastern Shore. The authors explain away this difference by saying that there may be a similar actual incidence rate, although the reported rates are different. It is suggested that African Americans do not notice one of the major signs-erythema migrans. Indeed, on the Upper Eastern Shore, erythema migrans has an incidence rate ratio of 5.7 (95 percent confidence interval: 2.4, 13.9) whereas, for other symptoms, such as extracutaneous manifestations and arthritis, the incidence rate ratios are only 0.9 (95 percent confidence interval: 0.6, 1.5) and 0.7 (95 percent confidence interval: 0.4, 1.1), respectively.
We would like to know whether the difference between reported incidence of Lyme disease among Whites and African Americans is truly because African-American people are indeed suffering from erythema migrans but do not notice it because of their dark skin. Have the authors looked into the state of health care in Maryland? It may be a common situation for African Americans to notice the erythema migrans, but they might be unaware of the significance of the rash or inhibited from consulting a doctor because of a lack of health insurance. This issue was not discussed by the authors.
The authors could have adjusted for the income status of cases or compared the findings with those from another state with different health care services. A study within the African-American population alone would be interesting in order to see how many people there are who have not registered as having Lyme disease but who do, in fact, have erythema migrans. It may then be possible to see whether or not the erythema migrans was noticed and, if so, why nothing was done about it. 
THE AUTHORS REPLY
We agree with El-Shanawany et al. (1) that our data allow us only to speculate about the reasons for the difference in reported erythema migrans (EM) between Whites and African Americans. There are likely multiple factors responsible for the difference. As noted in the Discussion section of our paper (2), we recognize that racial differences in the reporting of EM may be due to lack of awareness of the significance of the rash or to difficulties in access to care. Although adjustment for income status may provide some insight, our data do not contain such information. Certainly, further study would be necessary to specifically explore discrepancies between actual incidence and report of EM.
